Next-Generation Sequencing (NGS) Market, By Technology (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing and Others), By Application (Drug Discovery, Personalized Medicine & Genetic Screening, Disease Diagnosis, Agriculture & Animal Research and Others), By End User (Hospitals, Research Centers Pharma & Biotech Firms and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI140719 | Publish Date: June 2023 | No. of Pages: 168

Global NextGeneration Sequencing NGS Market Overview

Next-generation sequencing (NGS) is a massively parallel sequencing technology that can establish the order of nucleotides in a whole genome with scalability, ultra-high throughput, and fast speed. Because it includes preparing the sample for the subsequent sequencing reaction, DNA pre-sequencing is one of the most important processes in the total sequencing protocol. In the global healthcare sector, NGS is steadily being integrated into clinical laboratory analysis, testing, and disease diagnoses. In pharmacogenomics, NGS has been widely employed to speed up the drug discovery process. Global Next-Generation Sequencing (NGS) Market accounted for US$ 8.46 billion in 2020 and is estimated to be US$ 52.40 billion by 2030 and is anticipated to register a CAGR of 19.8%.

Global NextGeneration Sequencing NGS Market Dynamics

Increased genome mapping programs, increased applications of next generation sequencing

Increased genome mapping programs, increased applications of next generation sequencing, increased healthcare expenditure, and technological breakthroughs in sequencing platforms are all driving the global next generation sequencing industry forward. For example, in 2019, Thermo Fisher Scientific, a global leader in research, introduced the Ion Torrent Genexus System, a next-generation platform that can send specimens to report in as little as one day. In addition, Agilent Technologies, Inc., an American analytical development and production business, developed the Magnis NGS Prep Equipment in 2019, a next-generation sequencing library preparation system that is meant to execute complex sequencing assays with a single button press. NGS-based procedures such as non-invasive prenatal testing (NIPT) and pre-implantation genetic testing can reveal the foetus' genetic make-up and configuration (PGT). NGS-related R&D has risen to new heights as a result of increased investment in NGS technology around the world. The market is expected to grow because to an increase in demand for genome mapping programmes and the application of next-generation sequencing (NGS).

However, during the projection period, the scarcity of experienced specialists, as well as ethical and regulatory limitations connected with NGS, are projected to impede market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global NextGeneration Sequencing NGS Market Segmentation

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The global next-generation sequencing (NGS) market report segments the market on the basis of technology, application, end user, and region.

On the basis of Technology, the global oncology drug market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing and Others. On the basis of Application, the target market is segmented into Drug Discovery, Personalized Medicine & Genetic Screening, Disease Diagnosis, Agriculture & Animal Research and Others. Based on End User the market is segmented into Hospitals, Research Centers Pharma & Biotech Firms and Others.

Regional Insights:

Global Next-Generation Sequencing (NGS) Market accounted for US$ 8.46 billion in 2020 and is estimated to be US$ 52.40 billion by 2030 and is anticipated to register a CAGR of 19.8%. On region the global Next-Generation Sequencing (NGS) market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Within North America, the United States is predicted to have a significant share of the market, and this trend is expected to continue in the coming years. With the COVID-19 pandemic in this region, next-generation sequencing (NGS) technology is gaining prominence as a regular clinical diagnostic tool. The industry's expansion is aided by an increase in the number of strategic developments made by the region's main market players. For instance, Helix Laboratory's COVID-19 NGS test, which is an amplicon-based next-generation sequencing (NGS) test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper respiratory specimens for COVID-19 suspected persons, got FDA approval in August 2020. Similarly, the United States Food and Drug Administration accorded Pathogenomix Inc., a Next-Generation Sequencing pathogen testing business, Breakthrough Device Designation for their Patho-Seq assay in January 2022. (FDA).

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Technology - Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing and Others

By Application – Drug Discovery, Personalized Medicine & Genetic Screening, Disease Diagnosis, Agriculture & Animal Research and Others

By End User – Hospitals, Research Centers Pharma & Biotech Firms and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global next-generation sequencing (NGS) market report based on Technology, Application, End User and Region.

 

Global next-generation sequencing (NGS) Market, By Region:

 

  • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global NextGeneration Sequencing NGS Market Key Players

Key players in the global next-generation sequencing (NGS) market includes Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN LLC, PierianDx, Inc., F Hoffman-La Roche Ltd., Genomatix GmbH, Oxford Nanopore Technologies, Inc., Eurofins GATC Biotech GmbH, DNASTAR, Inc., Perkin, Elmer, Inc. and Bio-Rad Laboratories, Inc.

Global NextGeneration Sequencing NGS Market Company Profile

  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • QIAGEN LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PierianDx, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F Hoffman-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Genomatix GmbH
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Oxford Nanopore Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Eurofins GATC Biotech GmbH
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • DNASTAR, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Perkin Elmer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

 

Global NextGeneration Sequencing NGS Market Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Product Launch
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis
  4. Global Next-Generation Sequencing (NGS) Market, By Technology, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Whole Genome Sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  Whole Exome Sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  RNA Sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  Targeted Re-sequencing
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Next-Generation Sequencing (NGS) Market, By Application, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Drug Discovery
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    •  Personalized Medicine & Genetic Screening
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Disease Diagnosis
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Agriculture & Animal Research
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Next-Generation Sequencing (NGS) Market, By End-User, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Hospitals
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Research Centers Pharma & Biotech Firms
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
  • Overview
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Next-Generation Sequencing (NGS) Market, By Region, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Region, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      •  Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Illumina Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • QIAGEN
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • PierianDx, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • F Hoffman-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Genomatix GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Oxford Nanopore Technologies
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Eurofins GATC Biotech GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • DNASTAR, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Perkin Elmer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
    • Analyst Views
  3. Section
    • Research Methodology
    • About Us
    • Contact

 

FAQs

The global next-generation sequencing (NGS) market report segments the market on the basis of technology, application, end user, and region.

Increased genome mapping programs, increased applications of next generation sequencing, increased healthcare expenditure, and technological breakthroughs in sequencing platforms are all driving the global next generation sequencing industry forward.

Within North America, the United States is predicted to have a significant share of the market, and this trend is expected to continue in the coming years.

Key players in this market are Hoffmann-La Roche Ltd., Novartis International AG, Celgene Corporation, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., Eli Lilly and Company, AbbVie Inc., and Bayer AG.